CVS Health Corp

More Details of CVS Health Corp Company

CVS Health Corporation is a health solutions company. The Company's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. The Health Care Benefits segment offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, PDPs and Medicaid health care management services. The Health Services segment provides a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells an assortment of health and wellness products and general merchandise.

Company Info

Company codeCVS

Company nameCVS Health Corp

IPO dateOct 01, 1952

Founded at1996

CEOMr. J. David Joyner

Number of employees300000

Security typeOrdinary Share

Fiscal year-endOct 01

Address1 Cvs Dr

CityWOONSOCKET

Stock exchangeNYSE Consolidated

CountryUnited States of America

Postal code02895-6146

Phone14017651500

Websitehttps://cvshealth.com/

Company codeCVS

IPO dateOct 01, 1952

Founded at1996

Company Executives

Name

Name/Position

Position

Shareholding

Change

Mr. Larry Robbins

Independent Director

11.95M

--

Mr. Jean-Pierre (JP) Millon

Independent Director

112.22K

--

Mr. Tilak Mandadi

Executive Vice President, Chief Data, Digital, Analytics and Technology Officer

60.01K

+48.50%

Mr. Michael F. (Mike) Mahoney

Lead Independent Director

45.77K

+594.91%

Ms. Mary L. Schapiro, J.D.

Independent Director

11.84K

--

Mr. Guy P. Sansone

Independent Director

8.36K

--

Mr. Roger N. Farah

Executive Chairman of the Board

4.12K

-92.40%

Ms. Alecia A. DeCoudreaux, J.D.

Independent Director

2.97K

--

Mr. Douglas H. (Doug) Shulman, J.D.

Independent Director

2.20K

--

Ms. Leslie V. Norwalk

Director

2.20K

--

Name

Name/Position

Position

Shareholding

Change

Mr. Larry Robbins

Independent Director

11.95M

--

Mr. Jean-Pierre (JP) Millon

Independent Director

112.22K

--

Mr. Tilak Mandadi

Executive Vice President, Chief Data, Digital, Analytics and Technology Officer

60.01K

+48.50%

Mr. Michael F. (Mike) Mahoney

Lead Independent Director

45.77K

+594.91%

Ms. Mary L. Schapiro, J.D.

Independent Director

11.84K

--

Mr. Guy P. Sansone

Independent Director

8.36K

--

Revenue Breakdown

Currency: USDUpdate time: Sun, Apr 6

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

By BusinessUSD

Name

Revenue

Proportion

Pharmacy

210.27B

56.40%

Premiums

122.90B

32.96%

Front Store

21.52B

5.77%

Other

15.97B

4.28%

Net investment income(loss)

2.15B

0.58%

No Data

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

Pharmacy

210.27B

56.40%

Premiums

122.90B

32.96%

Front Store

21.52B

5.77%

Other

15.97B

4.28%

Net investment income(loss)

2.15B

0.58%

Shareholder

Update time: Sun, Apr 6

Shareholder Statistics

Type

Shareholder Statistics

Shareholder

Proportion

The Vanguard Group, Inc.

9.25%

Dodge & Cox

5.55%

Capital World Investors

4.84%

BlackRock Institutional Trust Company, N.A.

4.76%

State Street Global Advisors (US)

4.51%

Other

71.09%

Shareholder Statistics

Shareholder

Proportion

The Vanguard Group, Inc.

9.25%

Dodge & Cox

5.55%

Capital World Investors

4.84%

BlackRock Institutional Trust Company, N.A.

4.76%

State Street Global Advisors (US)

4.51%

Other

71.09%

Type

Shareholder

Proportion

Investment Advisor/Hedge Fund

36.76%

Investment Advisor

35.41%

Hedge Fund

3.92%

Research Firm

3.11%

Pension Fund

2.50%

Bank and Trust

1.74%

Sovereign Wealth Fund

1.55%

Individual Investor

1.06%

Insurance Company

0.09%

Other

13.85%

Institutional Shareholding

Update time: Sun, Jan 19

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q1

3678

1.09B

86.36%

+14.34M

2024Q4

3853

1.08B

85.46%

-1.57M

2024Q3

3812

1.05B

83.30%

-34.78M

2024Q2

3834

1.06B

84.02%

-4.44M

2024Q1

3863

1.03B

82.03%

-36.45M

2023Q4

3882

1.05B

81.65%

-1.13M

2023Q3

3770

1.04B

80.61%

-13.78M

2023Q2

3775

1.03B

80.60%

-13.09M

2023Q1

3785

1.03B

80.72%

-44.48M

2022Q4

3767

1.06B

81.84%

-22.75M

Shareholder Activity

Name

Shares Held

Proportion

Change

Chg %

Date

The Vanguard Group, Inc.

116.76M

9.25%

-239.74K

-0.20%

Dec 31, 2024

Dodge & Cox

70.11M

5.55%

+7.08M

+11.23%

Dec 31, 2024

Capital World Investors

61.04M

4.84%

+12.82M

+26.58%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

60.09M

4.76%

+324.23K

+0.54%

Dec 31, 2024

State Street Global Advisors (US)

56.95M

4.51%

+425.05K

+0.75%

Dec 31, 2024

Geode Capital Management, L.L.C.

27.05M

2.14%

+689.87K

+2.62%

Dec 31, 2024

Capital International Investors

26.67M

2.11%

+1.21M

+4.76%

Dec 31, 2024

Fidelity Management & Research Company LLC

21.14M

1.67%

-697.46K

-3.19%

Dec 31, 2024

Pzena Investment Management, LLC

19.61M

1.55%

+6.48M

+49.30%

Dec 31, 2024

Norges Bank Investment Management (NBIM)

18.70M

1.48%

+3.80M

+25.51%

Dec 31, 2024

Related ETFs

Update time: Sun, Apr 6

Name

Proportion

WBI Power Factor High Dividend ETF

6.23%

First Trust Consumer Staples Alphadex Fund

6.01%

Invesco S&P Ultra Dividend Revenue ETF

5.91%

Davis Select US Equity ETF

5.66%

iShares U.S. Healthcare Providers ETF

4.54%

VanEck Retail ETF

4.44%

iShares US Consumer Staples ETF

4.15%

iShares Large Cap Value Active ETF

3.42%

Invesco S&P 500 Enhanced Value ETF

3.42%

Burney US Factor Rotation ETF

3.42%

WBI Power Factor High Dividend ETF

Proportion6.23%

First Trust Consumer Staples Alphadex Fund

Proportion6.01%

Invesco S&P Ultra Dividend Revenue ETF

Proportion5.91%

Davis Select US Equity ETF

Proportion5.66%

iShares U.S. Healthcare Providers ETF

Proportion4.54%

VanEck Retail ETF

Proportion4.44%

iShares US Consumer Staples ETF

Proportion4.15%

iShares Large Cap Value Active ETF

Proportion3.42%

Invesco S&P 500 Enhanced Value ETF

Proportion3.42%

Burney US Factor Rotation ETF

Proportion3.42%

Dividend

A total of 14.66B USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

Jan 03, 2025

CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Feb 03, 2025 going ex on Jan 23, 2025

Jan 23, 2025

Feb 03, 2025

Jan 23, 2025

Sep 19, 2024

CVS.NB Final Cash Dividend of gross USD 0.665 paid on Nov 01, 2024 going ex on Oct 21, 2024

Oct 21, 2024

Nov 01, 2024

Oct 21, 2024

Jul 08, 2024

CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Aug 01, 2024 going ex on Jul 22, 2024

Jul 22, 2024

Aug 01, 2024

Jul 22, 2024

Mar 21, 2024

CVS.NB Interim Cash Dividend of gross USD 0.665 paid on May 01, 2024 going ex on Apr 19, 2024

Apr 22, 2024

May 01, 2024

Apr 19, 2024

Dec 06, 2023

CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Feb 01, 2024 going ex on Jan 19, 2024

Jan 22, 2024

Feb 01, 2024

Jan 19, 2024

Sep 21, 2023

CVS.NB Final Cash Dividend of gross USD 0.605 paid on Nov 01, 2023 going ex on Oct 19, 2023

Oct 20, 2023

Nov 01, 2023

Oct 19, 2023

Jul 07, 2023

CVS.NB Interim Cash Dividend of gross USD 0.605 paid on Aug 01, 2023 going ex on Jul 20, 2023

Jul 21, 2023

Aug 01, 2023

Jul 20, 2023

Mar 16, 2023

CVS.NB Interim Cash Dividend of gross USD 0.605 paid on May 01, 2023 going ex on Apr 20, 2023

Apr 21, 2023

May 01, 2023

Apr 20, 2023

Dec 15, 2022

CVS.NB Interim Cash Dividend of gross USD 0.605 paid on Feb 01, 2023 going ex on Jan 19, 2023

Jan 20, 2023

Feb 01, 2023

Jan 19, 2023

Sep 21, 2022

CVS.NB Final Cash Dividend of gross USD 0.55 paid on Nov 01, 2022 going ex on Oct 20, 2022

Oct 21, 2022

Nov 01, 2022

Oct 20, 2022

Stock Split

Date

Type

Ratio

No Data

Date

Type

Ratio

No Data

67.290USD

CVS Health Corp

67.290

Overview

Company